EuBiologics Co., Ltd. (KOSDAQ:206650)

EuBiologics Revenue

In the year 2024, EuBiologics had annual revenue of 96.04B KRW with 38.45% growth. EuBiologics had revenue of 26.89B in the quarter ending December 31, 2023, with 54.38% growth.

• Revenue: 96.04B
• Revenue Growth: +62.39%
• P/S Ratio: 3.25
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 312.39B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	96.04B	26.67B	38.45%
Dec 31, 2023	69.37B	13.90B	25.06%
Dec 31, 2022	55.47B	16.08B	40.83%
Dec 31, 2021	39.38B	10.90B	38.24%
Dec 31, 2020	28.49B	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2023

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 7, 2026

Data Sources Report a data error